Strides Shasun rises on completing USFDA audit for API Facility at Cuddalore

25 Apr 2017 Evaluate

Strides Shasun is currently trading at Rs. 1125.00, up by 24.60 points or 2.24% from its previous closing of Rs. 1100.40 on the BSE.

The scrip opened at Rs. 1132.00 and has touched a high and low of Rs. 1132.00 and Rs. 1120.15 respectively. So far 1,495 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1259.00 on 03-Feb-2017 and a 52 week low of Rs. 918.00 on 29-Aug-2016.

Last one week high and low of the scrip stood at Rs. 1132.00 and Rs. 1072.05 respectively. The current market cap of the company is Rs. 10,015.00 crore.

The promoters holding in the company stood at 31.09%, while Institutions and Non-Institutions held 48.89% and 20.02% respectively.

Strides Shasun’s API Facility at Cuddalore in the state of Tamil Nadu, has completed the audit by the US Food and Drug Administration (USFDA) with zero 483 observations.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and and semi-solids.


Strides Pharma Scien Share Price

880.10 10.70 (1.23%)
20-Jan-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1662.35
Dr. Reddys Lab 1166.30
Cipla 1387.60
Zydus Lifesciences 881.65
Lupin 2168.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×